Spelling suggestions: "subject:"peroxisome proliferator"" "subject:"peroxisome proliferators""
21 |
Sirt3, une déacetylase mitochondriale NAD+dépendante, est impliquée dans la regulation de la différenciation des myoblastes / SIRT3, a mitochondrial NAD+-dependent deacetylase is involved in the regulation of myoblast differentiationAbdel Khalek, Waed 22 March 2013 (has links)
Sirt3, une des sept sirtuines chez les mammifères, est une déacétylase mitochondriale NAD+-dépendante qui joue un rôle dans le contrôle des facteurs clés de plusieurs voies métaboliques. Sirt3 déacétyle et active un grand nombre d'enzymes mitochondriales impliquées dans l'activité de la chaîne respiratoire, la production d'ATP, le cycle de Krebs, ainsi que le cycle de l'urée. Parallèlement à son rôle dans le métabolisme énergétique, l'activité mitochondriale intervient également dans l'induction de l'apoptose ainsi que dans la régulation de la prolifération et la différenciation cellulaires. En particulier les travaux du laboratoire ont montré qu'il existe une véritable régulation de la différenciation myogénique par l'activité mitochondriale. Comme Sirt3 régule l'activité mitochondriale, nous nous sommes intéressés à étudier l'implication de cette sirtuine dans la différenciation des myoblastes. Dans une première partie, nous avons évalué l'expression endogène de Sirt3 au cours de la différenciation des myoblastes murins C2C12, puis étudié l'effet de son inhibition sur le processus de différenciation et sur l'activité mitochondriale. Nous avons montré que l'expression de Sirt3 endogène augmente après induction de la différenciation des C2C12. Une inhibition stable de l'expression de Sirt3 par interférence (Short hairpin Sirt3, shSirt3) entraîne : 1) un blocage de la différenciation terminale des C2C12 reflété par une chute significative de l'index de fusion ainsi que de l'expression des marqueurs myogéniques MyoD, Myogénine et troponine T ; 2) une diminution de l'activité mitochondriale reflétée par une altération de l'expression de PGC-1alpha, VDAC et citrate synthase, et une diminution des activités enzymatiques des complexes de la chaîne respiratoire et de la respiration maximale des myoblastes ; 3) une augmentation de la production de DROs. Ces résultats suggèrent un rôle important de Sirt3 dans la différenciation des myoblastes, en relation avec son influence sur l'activité mitochondriale.Dans une seconde partie, nous avons évalué l'importance de Sirt3 in vivo sur le développement et le métabolisme du tissu musculaire en étudiant le phénotype de souris surexprimant l'isoforme courte (MCK-SIRT3M3) ou l'isoforme longue (MCK-SIRT3M1) de Sirt3 spécifiquement dans le muscle squelettique. Nos premiers résultats obtenus à l'âge de 3 mois montrent que la capacité oxydative des souris MCK-SIRT3M1 est plus faible et celle des souris MCK-SIRT3M3 plus élevée par rapport aux souris sauvages. Les souris MCK-SIRT3M3 présentent une atrophie musculaire dès l'âge de trois mois alors que la capacité musculaire et l'activité mitochondriale dans les muscles de ces souris ne sont pas modifiées. Avec l'âge, le phénotype des souris surexprimant l'isoforme M3 dans le muscle est plus marqué : l'atrophie s'accentue, le nombre de mitochondries augmente, et l'expression de la myosine de type 1 augmente alors que l'expression des myosines de type II diminue. Ces données indiquent que l'isoforme courte de Sirt 3 aurait une influence dans le développement et le métabolisme du muscle squelettique de souris. / Sirt3, one of the seven mammalian sirtuins, is a mitochondrial nicotinamide adenine dinucleotide (NAD+)-dependent deacetylase, and has been shown to control multiple key metabolic pathways. Sirt3 deacetylates and activates a large number of mitochondrial enzymes implicated in the activity of respiratory chain and ATP production, TCA and Urea cycles. We have previously shown that mitochondrial activity is importantly involved in the regulation of myoblast differentiation. Since Sirt3 modulates mitochondrial activity, we have investigated its influence on myoblast differentiation. First, we have evaluated endogen Sirt3 expression during C2C12 myoblast differentiation and then we examined the effect of its inhibition on the differentiation processes and on mitochondrial activity. We have shown that Sirt3 protein expression increased after the induction of myoblast differentiation. A stable inhibition of Sirt3 expression, using short hairpin Sirt3 (shSirt3) in C2C12 myoblasts resulted in: 1) abrogation of terminal differentiation reflected by a sharp decrease of the fusion index and a significant decrease of Myogenin, MyoD and Troponin T protein expression; 2) a decrease in mitochondrial activity reflected by alterations in PGC1-alpha, VDAC and citrate synthase expression, and a decrease in respiratory chain complexes activity and myoblast maximal respiration, 3) an increase in ROS production. These data suggest that Sirt3 plays an important role in the regulation of myoblast differentiation through its influence on mitochondrial activity.In a second part, to investigate the role of Sirt3, in vivo, in myogenesis and in mitochondrial activity, we have studied the effect of Sirt3 isoforms (short and long, MCK-SIRT3M3 and MCK-SIRT3M1 respectively) overexpression exclusively in skeletal muscle tissue of transgenic mice. We show that basal metabolism is lower MCK-SIRT3M1 mice and higher in MCK-SIRT3M3 compared to WT mice at 3 months of age. In 3 month-old MCK-SIRT3M3 mice, skeletal muscle is atrophied while muscle capacity and mitochondrial activity are not altered. Skeletal muscle phenotype evolves with age, in MCK-SIRT3M3 mice : increase in muscle atrophy, mitochondrial content. These data suggest that Sirt3 short isoform plays an important role in skeletal muscle development and metabolism in mice.
|
22 |
Physiopathologie des anomalies du développement alvéolaire dans le RCIU : approche expérimentale et clinique / Pathophysiology of alveolarization growth disorder due to intrauterine growth restriction : clinical and experimental approachZana, Elodie 08 July 2014 (has links)
Une croissance intra-utérine insuffisante représente, avec la prématurité et les malfor-mations congénitales, une des principales causes de morbidité et de mortalité néonatales. Ces pathologies sont liées entre elles, les nouveau-nés prématurés étant souvent atteints de RCIU (RCIU). Les études épidémiologiques récentes ont montré que le RCIU était associé à une augmentation de la morbidité respiratoire dès la période néonatale, avec, en particulier, une augmentation du risque de dysplasie broncho-pulmonaire (DBP), principale séquelle respira-toire de la prématurité. La DBP est caractérisée par des anomalies du développement alvéo-laire et vasculaire, considérées comme les conséquences d’agressions multiples sur un poumon immature. La physiopathologie exacte reste encore largement méconnue. Nous nous sommes intéressés dans ce travail au lien entre RCIU et DBP avec un abord expérimental et clinique. Alors que les études épidémiologiques sont relativement concordantes sur le lien entre RCIU et DBP, les études expérimentales, montrent des résultats divers tant sur le développement pulmonaire qu’au niveau moléculaire. Nous avons donc voulu identifier, dans un premier temps, un modèle de RCIU reproduisant les anomalies du développement alvéolaire observées chez l’Homme en utilisant trois modèles précédemment validés chez le rat : un modèle de res-triction protidique per-gestationnelle , un modèle de ligature unilatérale de l’artère utérine, un modèle d’injection d’un inhibiteur chimique de la NO synthase, le L NAME. Seule la restric-tion protidique anténatale permet de reproduire à long terme des lésions de l’alvéolisation proches de celles observées dans la DBP. En revanche, dans ce modèle, les modifications des principaux gènes identifiés précédemment dans les anomalies le développement alvéolaire ne sont pas observées, que ce soit avant, pendant ou après l’alvéolisation. Ce résultat nous a ame-né à entreprendre une étude multigénique qui a permis d’identifier plusieurs voies modifiées pendant l’alvéolisation dans ce modèle. Parmi celles-ci, les gènes impliqués dans la contractili-té et l’adhésion cellulaire, l’immunité ou la voie des « Peroxisome Proliferator-Activated Re-ceptor ». Dans la partie clinique de cette étude, nous avons évalué le risque de DBP chez les extrêmes prématurés atteints de RCIU dont les mères présentaient des signes de pathologie vasculaire de la grossesse (prééclampsie). Cette étude rétrospective unicentrique sur 184 en-fants a permis de comparer des enfants atteints de RCIU à des enfants eutrophes pris en charge de manière homogène. Le RCIU d’origine vasculaire multiplie le risque de DBP par 6. Un marqueur précoce de l’évolution vers une DBP est un taux de plaquettes bas à la naissance, évoquant le rôle d’un taux élevé de facteurs anti-angiogéniques circulants. Une étude est en cours pour corréler les facteurs anti-angiogéniques circulants présents chez les mères pré-éclamptiques au devenir respiratoire, en particulier à l’évolution vers une DBP, de leurs nou-veau-nés d’âge gestationnel inférieur à 30 semaines d’aménorrhée. En conclusion, nous avons montré expérimentalement que seule la restriction protidique anténatale chez le rat reproduisait les troubles de l’alvéolisation comparables à ceux observés dans la DBP. De nouvelles voies moléculaires potentiellement impliquées dans les anomalies de l’alvéolisation ont été mises en évidence. Par ailleurs, le rôle de facteurs anti-angiogéniques d’origine maternelle comme fac-teurs de développement d’une DBP est en cours d’évaluation. / Insufficient intrauterine growth is with prematurity and congenital malformations, a major cause of neonatal morbidity and mortality. These conditions are interrelated, the preterm infants often suffered of intrauterine growth restriction (IUGR). Recent epidemiological stud-ies showed that IUGR was associated with increased respiratory morbidity as soon as the ne-onatal period, with an increased risk of bronchopulmonary dysplasia (BPD), the main respira-tory sequelae of prematurity. BPD is characterized by impaired alveolar and vascular devel-opment and is the consequence of multiple insults on an immature lung. The exact pathophysi-ology is still largely unknown. We study in this work the relationship between IUGR and DBP with an experimental and clinical approach. While epidemiological studies are relatively concordant on the relationship between IUGR and BPD, experimental studies showed various results in lung development and molecular process. We wanted to identify, at first, a model of IUGR reproducing impaired alveolar development observed in humans using three previously validated models in rats: a model of per-gestational protein restriction, a model of unilateral ligation uterine artery, an injection pattern of a chemical inhibitor of NO synthase, L NAME. Only antenatal protein restriction can reproduce long-term impaired alveolarization as those observed in BPD. However, in this model, changes in key genes previously identified in pathological alveolar development are not observed before, during or after alveolarization. This result led us to perform a genome-wide analysis which identified several modified path-ways during alveolarization. Among these, the genes involved in the “cardiac contractility”, “cell adhesion molecules”, “immunity”, “molecular adhesion” or the "Peroxisome Proliferator-Activated Receptor" pathways. In the clinical part of this study, we evaluated the risk of BPD in extreme preterm infants with IUGR whose mothers had evidence of vascular disease of pregnancy (preeclampsia). This single-center retrospective study of 184 children was used to compare children with IUGR in adjusted for gestational age children. The vascular IUGR increases the risk of DBP by 6. An early marker of progression to BPD is a low platelet count at birth, referring to the role of high levels of circulating anti-angiogenic factors. A study is ongoing to correlate circulating anti-angiogenic factors present in preeclamptic mothers to res-piratory outcome and particularly BDP, in newborn younger than 30 weeks of gestational age at birth. In conclusion, we have shown experimentally that only prenatal protein restriction in rats reproduced impaired alveolarization comparable to those observed in the BPD. New mo-lecular pathways potentially involved in the impaired alveolarization were highlighted. More-over, the role of placental anti-angiogenic factors leading to development of BPD is evaluat-ed.
|
23 |
Characterizing the Binding Potential, Activity, and Bioaccessibility of Peroxisome Proliferator Activated Receptor Gamma (PPARγ) Ligands in Indoor DustFANG, MINGLIANG January 2015 (has links)
<p>Accumulating evidence is suggesting that exposure to some environmental contaminants may alter adipogenesis, resulting in accumulation of adipocytes, and often significant weight gain. Thus these types of contaminants are often referred to as obesogens. Many of these contaminants act via the activation (i.e. agonism) of the peroxisome proliferator activated receptor γ (PPARγ) nuclear receptor. To date, very few chemicals have been identified as possible PPAR ligands. In the thesis, our goal was to determine the PPARγ ligand binding potency and activation of several groups of major semi-volatile organic compounds (SVOCs) that are ubiquitously detected in indoor environments, including flame retardants such as polybrominated diphenyl ethers (PBDEs) and Firemaster 550 (FM550), and other SVOCs such as phthalates, organotins, halogenated phenols and bisphenols. Additional attention was also given to the potential activity of the major metabolites of several of these compounds. Since the primary sink for many of these SVOCs is dust, and dust ingestion has been confirmed as an important pathway for SVOCs accumulation in humans, the potential PPAR binding and activation in extracts from environmentally relevant dust samples was also investigated. </p><p> Previous studies have also shown that SVOCs sorbed to organic matrices (e.g., soil and sediment), were only partially bioaccessible (bioavailable), but it was unclear how bioaccessible these compounds are from indoor dust matrices. In addition, bioactivation of SVOCs (via metabolism) could exacerbate their PPAR potency. Therefore, to adequately assess the potential risk of PPARγ activation from exposure to SVOC mixtures in house dust, it is essential that one also investigates the bioaccessibility and bioactivation of these chemicals following ingestion. </p><p> In the first research aim of this thesis, the bioaccessibility and bioactivation of several important SVOCs in house dust was investigated. To accomplish this, Tenax beads (TA) encapsulated within a stainless steel insert were used as an infinite adsorption sink to estimate the dynamic absorption of a suite of flame retardants (FRs) commonly detected in indoor dust samples, and from a few polyurethane foam samples for comparison. Experimental results demonstrate that the bioaccessibility and stability of FRs following ingestion varies both by chemical and by matrix. Organophosphate flame retardants (OPFRs) had the highest estimated bioaccessibility (~80%) compared to brominated compounds (e.g. PBDEs), and values generally decreased with increasing Log Kow, with <30% bioaccessibility measured for the most hydrophobic compound tested, BDE209. In addition, the stability of the more labile SVOCs that contained ester groups (e.g. OPFRs and 2-ethylhexyl-tetrabromo-benzoate (TBB)) were examined in a simulated digestive fluid matrix. No significant changes in the OPFR concentrations were observed in this fluid; however, TBB was found to readily hydrolyze to tetrabromobenzoic acid (TBBA) in the intestinal fluid in the presence of lipases. </p><p> In research aims 2 and 3, two commercially available high-throughput bioassays, a fluorescence polarization PPAR ligand binding assay (PolarScreenTM PPARγ-competitor assay kit, Invitrogen, Aim 2) and a PPAR reporter gene assay (GeneBLAzer PPARγ non-DA Assay, Invitrogen, Aim 3) were used to investigate the binding potency and activation of several groups of SVOCs and dust extracts with human PPARγ LBD; respectively. In the PPAR binding assay (Aim 2), most of the tested compounds exhibited dose-dependent binding to PPARγ. Mono(2-ethylhexyl) tetrabromophthalate (TB-MEHP), halogenated bisphenol/phenols, triphenyl phosphate and hydroxylated PBDEs were found to be potent or moderate PPARγ ligands, based on the measured ligand binding dissociation constant (Kd). The most potent compound was 3-OH-BDE47, with an IC50 of 0.24 μM. The extent of halogenation and the position of the hydroxyl group strongly affected binding. Of the dust samples tested, 21 of 24 samples showed significant PPAR binding potency at a concentration of 3 mg dust equivalents (DEQ)/mL. In the PPAR reporter assay (Aim 3), many SVOCs or their metabolites were either confirmed (based on previous reports) or for the first time were found to be potential PPARγ agonists with various potency and efficacy. We also observed that 15 of 25 dust extracts examined showed an activation percentage more than 8% (calculated activation threshold) of the maximal activation induced by rosiglitazone (positive control). In some cases, activation was as high as 50% of the rosiglitazone activation for the dust extracts with the highest efficacy. Furthermore, the correlation between the reporter assay and the ligand binding assay among the house dust extracts was significant and positive (r = 0.7, p < 0.003), suggesting the binding potency was predicting activation. In research aim 2, the effect of bioactivation on the PPARγ binding potency was also investigated. In vitro bioactivation of house dust extracts incubated with rat and human hepatic S9 fractions was used to investigate the role of in vivo biotransformation on PPAR gamma activity. The result showed that metabolism may lead to an increased binding affinity, as a 3-16% increase in PPARγ binding activity was observed following bioactivation of the dust extracts.</p><p> In research aim 4, an effect-directed analysis (EDA) was used to identify compounds likely contributing to the observed PPAR activity among the dust extract. Three dust extracts which showed significant PPAR activity with approximately 25, 30, and 50% of the maximal response induced by rosiglitazone at the highest efficacy were fractionated using normal phase high-performance liquid chromatography (NP-HPLC) and each fraction was individually tested for PPAR activity. Active fractions were then analyzed using gas-chromatography mass spectrometry (GC-MS) and possible compounds identified. Three dust extracts showed a similar PPAR activity distribution among the NP-HPLC fractions. In the most active fractions, fatty acids (FAs) were identified as the most active chemicals. The concentrations of four FAs were measured in the house dust extracts, and the concentrations were found to be highly correlated with the observed PPAR activity. These four FAs were also tested for PPAR activity and found to be partial PPAR agonists, particularly oleic and myristic acid. To tentatively identify sources of FAs, FAs in human/animal hair, dead skin cells, and two brands of cooking oil were analyzed. We found the same FAs in those samples and there concentrations were relatively abundant, ranging from 186 to 14,868 µg/g. Therefore, these results suggest that FAs are likely responsible for the observed PPAR activity in indoor dust. Also, this is the first study reporting on the level of FAs in dust samples. The source of these FAs in dust may be either from the cooking or accumulation of human/animal cells in indoor dust.</p><p> In conclusion, this research demonstrates that many SVOCs ubiqutiously detected in house dust, and/or their metabolites, can be weak or moderate PPAR ligands. In addition, chemical mixtures in house dust can effectively bind to and activate PPAR. However, our results suggest FAs are probably responsible for these observations, and likely outcompeting the synthetic environmental contaminants present in the dust extract. Furthermore, bioactivation of contaminants present in house dust can potentially increase their affinity for PPAR. And lastly, the bioaccessibility and stability of SVOCs in house dust after ingestion are likely to modulate the PPAR activity in the environmental mixtures and should be considered in future risk assessments.</p> / Dissertation
|
24 |
Enhanced methylglyoxal formation in cystathionine γ-lyase knockout miceUntereiner, Ashley Anne 24 June 2011
<p>Methylglyoxal (MG) is a reactive glucose metabolite and a known causative factor for hypertension and diabetes. Hydrogen sulfide (H<sub>2</sub>S), on the other hand, is a gasotransmitter with multifaceted physiological functions, including anti-oxidant and vasodilatory properties. The present study demonstrates that MG and H<sub>2</sub>S can interact with and modulate each other's functions. Upon <i>in vitro</i> incubations, we found that MG and H<sub>2</sub>S can directly interact to form three possible MG-H<sub>2</sub>S adducts. Furthermore, the endogenous production level of MG or H<sub>2</sub>S was significantly reduced in a concentration-dependent manner in rat vascular smooth muscle cells (A-10 cells) treated with NaHS, a H<sub>2</sub>S donor, or MG, respectively. Indeed, MG-treated A-10 cells exhibited a concentration-dependent down-regulation of the protein and activity level of cystathionine γ-lyase (CSE), the main H<sub>2</sub>S-generating enzyme in the vasculature. Moreover, H<sub>2</sub>S can induce the inhibition of MG-generated ROS production in a concentration-dependent manner in A-10 cells. In 6-22 week-old CSE knockout male mice (CSE<sup>-/-</sup>), mice with lower levels of vascular H<sub>2</sub>S, we observed a significant elevation in MG levels in both plasma and renal extracts. Renal triosephosphates were also significantly increased in the 6-22 week-old CSE<sup>-/-</sup> mice. To identify the source of the elevated renal MG levels, we found that the activity of fructose-1,6-bisphosphatase (FBPase), the rate-limiting enzyme in gluconeogenesis, was significantly down-regulated, along with lower levels of its product (fructose-6-phosphate) and higher levels of its substrate (fructose-1,6-bisphosphate) in the kidney of 6-22 week-old CSE<sup>-/-</sup> mice. We have also observed lower levels of the gluconeogenic regulator, peroxisome
proliferator-activated receptor-γ coactivator (PGC)-1α, and its down-stream targets, FBPase-1 and -2, phosphoenolpyruvate carboxykinase (PEPCK), and estrogen-related receptor (ERR)α mRNA expression levels in renal extracts from 6-22 week-old CSE<sup>-/-</sup> mice. Likewise, FBPase-1 and -2 mRNA levels were also significantly down-regulated in aorta tissues from 14-16 week-old CSE<sup>-/-</sup> mice. Administration of 30 and 50 µM NaHS induced a significant increase in FBPase-1 and PGC-1α in rat A-10 cells. We have also observed a significant up-regulation of PEPCK and ERRα mRNA expression levels in 50 µM NaHS-treated A-10 cells, further confirming the involvement of H<sub>2</sub>S in regulating the rate of gluconeogenesis and MG formation. Overall, this unique study demonstrates the existence of a negative correlation between MG and H<sub>2</sub>S in the vasculature. Further elucidation of this cross-talk phenomenon between MG and H<sub>2</sub>S could lead to more elaborate and effective therapeutic regimens to combat metabolic syndrome and its related health complications.</p>
|
25 |
An Oxidized Fat Containing Diet Decreases Weight Gain but Increases Adiposity in Mice Fed a Low Fat DietSchneider, Mary Katherine 14 September 2009 (has links)
Introduction: Fast and convenience foods are abundant, relatively inexpensive, and accommodating to the fast-paced lifestyle of many Americans. One popular method of cooking used by many fast food establishments is deep-fat frying. Soybean oil is commonly used for frying and is rich in polyunsaturated fatty acids (PUFA) such as linoleic acid (LA). When soybean oil is used for deep-fat frying, LA becomes oxidized (Ox-LA). Endogenous Ox-LA has the capacity to be a ligand to peroxisome proliferator-activated receptor gamma (PPAR¥ã), a nuclear transcription factor that regulates adipocyte maturation. It is not yet known whether or not dietary Ox-LA has the same capacity with respect to PPAR¥ã. Considering the fact that dietary oxidized lipids are abundant in the typical American diet, it is important to know if they regulate weight gain and especially adipose tissue mass. In this study, we investigate the effects of fresh and heated soybean oil on weight gain and adiposity in mice fed isocaloric low fat diets. Methods: Soybean oil was heated on a hot plate, under a hood, at 190¨¬C for three hours. Fresh soybean oil served as the source of unoxidized oil (Unox-oil) and the heated oil served as the source of oxidized oil (Ox-oil). Both the Ox-oil and Unox-oil were incorporated into a low-fat (10% of calories) mouse chow by Research Diets, Inc. (New Brunswick, NJ). Sixteen C57BL/6J mice were divided into two groups and fed low fat diets with Ox-oil (low fat oxidized, LFO) or with Unox-oil (low fat unoxidized, LFU). Another group of 8 mice were pair fed to the LFO group with the Unox-oil containing chow (PLU). Mice in the LFO and LFU groups were fed ad libitum and known amounts of fresh food was added to the cages every three days. Leftover food was weighed. Body weights were measured once a week. After 16 weeks mice were euthanized and epididymal white adipose tissue (EWAT), retroperitoneal white adipose tissue (RWAT), inguinal white adipose tissue (IWAT), and intrascapular brown adipose tissue (IBAT) samples were collected, weighed and stored at -80 degrees Celsius until further analysis. Fat pads were homogenized and cytosolic and nuclear proteins were extracted by standard methods. These extracts were subjected to Western blotting to determine the amount of PPAR¥ã in the cytosol and nuclear compartments of the fat pads. Differences in group means were analyzed by Mann Whitney U test. Comparisons were considered statistically significant at a p-value of < 0.05. Results: Final mean body weights were significantly different when comparing the mice in the LFU group to the pair fed mice (PLU) (mean ¡¾ SD; 29.52 ¡¾ 1.09 grams (g) and 26.85 ¡¾ 1.44 g, respectively; p < 0.05). Mice fed a low fat diet consisting of Ox-oil (LFO) had a final mean body weight of 27.88 ¡¾ 2.03 g. Mice in the LFU group gained significantly more weight on average than did mice in the LFO or PLU groups (mean ¡¾ SD; 8.86 ¡¾ 1.37g, 7.10 ¡¾ 1.47 g, and 5.71 ¡¾ 1.13 g, respectively). Although mean food intakes were not significantly different between any of the three groups, the average food intake was greatest for the LFU mice in comparison to the LFO and the PLU mice (mean ¡¾ SD; 20.65 ¡¾ 0.09 g/week, 18.40 ¡¾ 0.05 g/week, and 18.38 ¡¾ 0.19 g/week, respectively). Feeding efficiency (g of weight gain/g of food consumed) was the highest in the LFU mice compared to the PLU mice (mean ¡¾ SD; 0.031 ¡¾ 0.005 g/g and0.022 ¡¾ 0.004 g/g) and this difference was statistically significant. The LFO mice gained less weight per gram of food consumed than did the LFU mice (mean ¡¾ SD; 0.028 ¡¾ 0.006 g/g). Mean weights of all fat pads in the LFO group were significantly greater than those of the LFU and PLU mice (mean ¡¾ SD; 0.329 ¡¾ 0.109g, 0.199 ¡¾ 0.055g, and 0.219 ¡¾ 0.041 for EWAT, 0.091 ¡¾ 0.039g, 0.050 ¡¾ 0.026g, and 0.051 ¡¾ 0.017 for RWAT, 0.221 ¡¾ 0.065g, 0.135 ¡¾ 0.053g, and 0.144 ¡¾ 0.038 for IWAT, and 0.079 ¡¾ 0.012g, 0.055 ¡¾ 0.013g, and 0.062 ¡¾ 0.011 for IBAT, respectively). PPAR¥ã protein in the cytosol of EWAT fat pads was analyzed and quantified in comparison to the amount of Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; loading control) present. Mean PPAR¥ã /GAPDH ratios for LFU mice was 0.226 ¡¾ 0.082, for LFO mice was 0.264 ¡¾ 0.122, and for PLU mice was 0.234 ¡¾ 0.108. Mean PPAR¥ã:GAPDH ratios were not significantly different between any of the groups. Conclusion: It appears that the consumption of oxidized oil caused a significant decrease in weight gain and food intake (although not significant) and a significant increase in fat pad mass in mice compared to those consuming a diet with unoxidized oil. The lack of difference in the amount of PPAR¥ã among the three groups of mice suggests that the changes in weight gain and fat pad mass among the oxidized oil consuming animals is not mediated through regulation of PPAR¥ã protein. To our knowledge, ours is the first study to report that mice consuming a low fat diet inclusive of dietary oxidized lipids exhibit greater adiposity than do mice consuming a low fat diet consisting of unoxidized lipids.
|
26 |
Enhanced methylglyoxal formation in cystathionine γ-lyase knockout miceUntereiner, Ashley Anne 24 June 2011 (has links)
<p>Methylglyoxal (MG) is a reactive glucose metabolite and a known causative factor for hypertension and diabetes. Hydrogen sulfide (H<sub>2</sub>S), on the other hand, is a gasotransmitter with multifaceted physiological functions, including anti-oxidant and vasodilatory properties. The present study demonstrates that MG and H<sub>2</sub>S can interact with and modulate each other's functions. Upon <i>in vitro</i> incubations, we found that MG and H<sub>2</sub>S can directly interact to form three possible MG-H<sub>2</sub>S adducts. Furthermore, the endogenous production level of MG or H<sub>2</sub>S was significantly reduced in a concentration-dependent manner in rat vascular smooth muscle cells (A-10 cells) treated with NaHS, a H<sub>2</sub>S donor, or MG, respectively. Indeed, MG-treated A-10 cells exhibited a concentration-dependent down-regulation of the protein and activity level of cystathionine γ-lyase (CSE), the main H<sub>2</sub>S-generating enzyme in the vasculature. Moreover, H<sub>2</sub>S can induce the inhibition of MG-generated ROS production in a concentration-dependent manner in A-10 cells. In 6-22 week-old CSE knockout male mice (CSE<sup>-/-</sup>), mice with lower levels of vascular H<sub>2</sub>S, we observed a significant elevation in MG levels in both plasma and renal extracts. Renal triosephosphates were also significantly increased in the 6-22 week-old CSE<sup>-/-</sup> mice. To identify the source of the elevated renal MG levels, we found that the activity of fructose-1,6-bisphosphatase (FBPase), the rate-limiting enzyme in gluconeogenesis, was significantly down-regulated, along with lower levels of its product (fructose-6-phosphate) and higher levels of its substrate (fructose-1,6-bisphosphate) in the kidney of 6-22 week-old CSE<sup>-/-</sup> mice. We have also observed lower levels of the gluconeogenic regulator, peroxisome
proliferator-activated receptor-γ coactivator (PGC)-1α, and its down-stream targets, FBPase-1 and -2, phosphoenolpyruvate carboxykinase (PEPCK), and estrogen-related receptor (ERR)α mRNA expression levels in renal extracts from 6-22 week-old CSE<sup>-/-</sup> mice. Likewise, FBPase-1 and -2 mRNA levels were also significantly down-regulated in aorta tissues from 14-16 week-old CSE<sup>-/-</sup> mice. Administration of 30 and 50 µM NaHS induced a significant increase in FBPase-1 and PGC-1α in rat A-10 cells. We have also observed a significant up-regulation of PEPCK and ERRα mRNA expression levels in 50 µM NaHS-treated A-10 cells, further confirming the involvement of H<sub>2</sub>S in regulating the rate of gluconeogenesis and MG formation. Overall, this unique study demonstrates the existence of a negative correlation between MG and H<sub>2</sub>S in the vasculature. Further elucidation of this cross-talk phenomenon between MG and H<sub>2</sub>S could lead to more elaborate and effective therapeutic regimens to combat metabolic syndrome and its related health complications.</p>
|
27 |
Cardioprotective mechanisms by inhibition of the HMG-CoA reductase pathway and stimulation of peroxisome proliferator-activated receptors in myocardial ischaemia-reperfusion /Bulhak, Aliaksandr, January 2007 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 4 uppsatser.
|
28 |
Nuclear Receptor Activation and Alzheimer's Disease PathogenesisCramer, Paige E. 22 May 2012 (has links)
No description available.
|
29 |
CHARACTERIZATION AND MOLECULAR REGULATION OF METABOLIC AND MUSCLE FLEXIBILITY IN A NEOTROPICAL MIGRANT, <i>DUMETELLA CAROLINENSIS</i> (GRAY CATBIRD)DeMoranville, Kristen J. 14 July 2015 (has links)
No description available.
|
30 |
THE ROLE OF AMPK IN THE EXPRESSION OF THE DAPC / THE ROLE OF AMPK IN THE EXPRESSION OF THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX IN SKELETAL MUSCLEDial, Athan January 2017 (has links)
The dystrophin-associated protein complex (DAPC) provides a mechanical link between the intracellular cytoskeleton and extracellular matrix, serving as a mechanosensor and signal transducer across the sarcolemma. Pharmacological stimulation of AMP-activated protein kinase (AMPK) induces the expression of DAPC components in skeletal muscle, whereas physiological reductions in AMPK are associated with DAPC dysfunction. We sought to determine whether AMPK was necessary for the maintenance of DAPC expression in skeletal muscle. Fast glycolytic extensor digitorum longus (EDL) and slow oxidative soleus (SOL) muscles from wild-type (WT) mice, as well as from littermates deficient in both isoforms of the AMPK-β subunit in skeletal muscle (MKO) were analyzed. DAPC mRNA levels, as well as protein expression and localization were similar between genotypes, with the exception of nNOS, which displayed a compensatory sarcolemmal enrichment in MKO muscles. The content of transcriptional and post-transcriptional regulators of the DAPC, such as PGC-1α and KSRP, were also not affected by the loss of AMPK. However, MyoD and myogenin expression was significantly diminished in MKO muscles, which is consistent with previous reports of myopathy in these animals. Furthermore, we observed decrements in extrasynaptic utrophin expression selectively in MKO SOL muscles, despite an adaptive accumulation of PGC-1α at the sarcolemmal compartment. Collectively the evidence indicates that AMPK is sufficient, but not essential for the maintenance of DAPC expression in skeletal muscle. However, AMPK is required for preserving extrasynaptic utrophin levels in slow, oxidative muscles, which underscores the role of AMPK in the gene expression of this disease modifying protein. / Thesis / Master of Science (MSc) / The dystrophin-associated protein complex (DAPC) connects the interior and exterior of muscle cells. Activation of AMP-activated protein kinase (AMPK) increases the expression of the DAPC in skeletal muscle. We sought to determine whether AMPK was necessary for DAPC expression in skeletal muscle. Fast and slow muscles from normal mice, as well as from those deficient in skeletal muscle AMPK (MKO) were analyzed. We found DAPC levels and localization were similar between both groups, with the exception of nNOS, which was enriched at the muscle membrane in MKO muscles. Regulators of the DAPC were also not affected by the loss of AMPK. However, genes important for the production of muscle were significantly diminished in MKO muscles. Furthermore, we observed decrements in utrophin at the muscle membrane selectively in slow MKO muscles. Our work indicates that AMPK is not essential for the DAPC expression in skeletal muscle, however it is required for preserving utrophin levels in slow, oxidative muscles.
|
Page generated in 0.0526 seconds